Skip to main content
SpringerLink
Log in

In vitro and in vivo evaluation of single-unit commercial conventional tablet and sustained-release capsules compared with multiple-unit polystyrene microparticle dosage forms of ibuprofen

  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

The major aims of the present study were (1) to select a multiple-unit formulation that matched the in vitro dissolution profile of single-unit sustained-release commercial capsules, (2) to compare the sustaining/controlling efficacy of the selected multiple-unit formulation with that of the single-unit commercial conventional tablet and sustained-release capsules, and (3) to determine whether an in vitro-in vivo correlation exists for single- and multiple-unit formulations. Ibuprofen (20%–60% wt/wt)-loaded multiple-unit polystyrene microparticles were prepared by an emulsion-solvent evaporation method from an aqueous system. The in vitro release profiles obtained in phosphate buffer of pH 6.8 for drug-loaded polystyrene microparticles and for commercial sustained-release capsules (Fenlong-SR, 400 mg) were compared. Since the microparticles with 30% ibuprofen load showed a release profile comparable to that of the Fenlong-SR release profile, the microparticles with this drug load were considered to be the optimized/selected formulation and, therefore, were subjected to stability study and in vivo study in human volunteers. A single-dose oral bioavailability study revealed significant differences in Cmax, Tmax, t1/2a, t1/2e, Ka, Ke, and AUC between the conventional tablet and optimized or Fenlong-SR capsule dosage forms. However, all the parameters, with the exception of Ka along with relative bioavailability (F) and retard quotient (RΔ), obtained from the optimized ibuprofenloaded microparticles were lower than that obtained from the commercial Fenlong-SR formulation. Furthermore, linear relationship obtained between the percentages dissolved and absorbed suggests a means to predict in vivo absorption by measuring in vitro dissolution.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bechgaard H, Nielsen GH. Controlled-release multiple-units and single-unit doses. A literature review.Drug Dev Ind Pharm. 1978; 4:53–67.

    Article  CAS  Google Scholar 

  2. Beckett AH. Altermative routes of drug administration and new drug delivery systems. In: Breimer DD, ed.Towards Better Safety of Drugs and Pharmaceutical Products. New York, NY: Elsevier/North-Holland Biomedical Press; 1980:247–263.

    Google Scholar 

  3. Davis SS, Hardy JG, Taylor MJ, Whalley DR, Wilson CG. A comparative study of the gastrointestinal transit of a pellet and tablet formulation.Int J Pharm. 1984;21:167–177.

    Article  CAS  Google Scholar 

  4. Gennaro AR, Chase GD, Der Marderosian A, eds.Remington’s Pharmaceutical Sciences, 18th ed. Easton, PA: Mack Publishing Company; 1990.

    Google Scholar 

  5. Rossi S.Australian Medicines Handbook 2004. Adelaide, Australia: Australian Medicines Handbook; 2004.

    Google Scholar 

  6. Tamilvanan S, Sa B. Effect of production variables on the physical characteristics of ibuprofen-loaded opolystyrene microparticles.J Microencapsul. 1999;16:411–418.

    Article  CAS  Google Scholar 

  7. United States Pharmacopoeia XXII. Rockville, MD: US Pharmacopoeial Convention Inc; 1990.

  8. British Pharmaceutical Codex. London, UK: Pharmaceutical Press; 1976.

  9. Higuchi T. Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices.J Pharm Sci. 1963;52:1145–1149.

    Article  CAS  Google Scholar 

  10. Bamba M, Puisieux F, Marty JP, Carstensen JT. Release mechanisms in gelforming sustained release preparations.Int J Pharm. 1979;2: 307–315.

    Article  CAS  Google Scholar 

  11. Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation, I: theoretical considerations.Ind Eng Chem. 1931;23:923–931.

    Article  CAS  Google Scholar 

  12. Shah MV, De Gennaro MD, Suryakasuma H. An evaluation of albumin microcapsules prepared using a multiple emulsion technique.J Microencapsul. 1987;4:223–238.

    Article  CAS  Google Scholar 

  13. Lund W.The Pharmaceutical Codex. London, UK: Pharmaceutical Press; 1994.

    Google Scholar 

  14. Adeyeye CM, Price JC. Chemical, dissolution stability and microscopic evaluation of suspensions of ibuprofen and sustained release ibuprofen-wax microspheres.J Microencapsul. 1997;14: 357–377.

    Article  CAS  Google Scholar 

  15. Lamprecht A, Saumet JL, Roux J, Benoit JP. Lipid nanocarriers as drug delivery system for ibuprofen in pain treatment.Int J Pharm. 2004;278:407–414.

    Article  CAS  Google Scholar 

  16. Rowland M, Tozer TN.Clinical Pharmacokinetics: Concepts and Applications. New Delhi, India: BI Waverly Pvt Ltd; 1996:478–480.

    Google Scholar 

  17. Rowland M, Tozer TN.Clinical Pharmacokinetics: Concepts and Applications New Delhi, India: BI Waverly Pvt Ltd; 1996:469–472.

    Google Scholar 

  18. Silber M, Bialer M, Yacobi A. Pharmacokinetic and pharmacodynamic basis of controlled drug delivery. In: Robinson JR, Lee VHL, eds.Controlled Drug Delivery, Fundamentals and Application. New York, NY: Marcel Dekker; 1987:225–230.

    Google Scholar 

  19. Maturu PK, Prasad VK, Worsley WN, Shiu GK, Skelly JP. Influence of a high fat breakfast on the bioavailability of theophylline controlled-release formulations: an in vivo observation.J Pharm Sci. 1986;75:1205–1206.

    Article  CAS  Google Scholar 

  20. Tamilvanan S, Biswanath SA. Effect of drug-load on the internal structure of ibuprofen-loaded polystyrene microparticles.Acta Pol Pharm. 1999;56:221–226.

    CAS  Google Scholar 

  21. Block LH, Banakar UV. Further considerations in correlating in vitro-in vivo data employing mean time concept based on statistical moments.Drug Dev Ind Pharm. 1988;14:2143–2150.

    Article  CAS  Google Scholar 

  22. Benet LZ. Design and optimization of dosage regimens: pharmacokinetic data. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Goodman AG, eds.Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 9th ed. New York, NY: McGraw-Hill; 1996:1702–1792.

    Google Scholar 

  23. Riegelman S, Collier P. The application of statistical moment theory to the evaluation of in vivo dissolution time and absorption time.J Pharmacokinet Biopharm. 1980;8:509–534.

    Article  CAS  Google Scholar 

  24. Shargel L, Yu ABC.Applied Biopharmaceutics and Pharmacokinetics. New York, NY: Prentice-Hall International Inc; 1993:505.

    Google Scholar 

  25. Meier J, Nuesch E, Schmidt R. Pharmacokinetic criteria for the evaluation of retard formulations.Eur J Clin Pharmacol. 1974;7:429–432.

    Article  CAS  Google Scholar 

  26. Borin MT, Khare S, Beihn RM, Jay M. The effect of food on gastrointestinal (GI) transit of sustained-release ibuprofen tablets as evaluated by gamma scintigraphy.Pharm Res. 1990;7:304–307.

    Article  CAS  Google Scholar 

  27. Wilson WI, Peng Y, Augsburger LL. Comparison of statistical analysis and Bayesian networks in the evaluation of dissolution performance of BCS Class II model drugs.J Pharm Sci. 2005;94: 2764–2776.

    Article  CAS  Google Scholar 

  28. Kottke MK, Rhodes CT. Limitations of presently available in vitro release data for the prediction of in vivo performance.Drug Dev Ind Pharm. 1991;17:1157–1176.

    Article  CAS  Google Scholar 

  29. Reynolds JEF.Martindale, The Extra Pharmacopoeia. London, UK: Royal Pharmaceutical Society; 1996:50.

    Google Scholar 

  30. FDA Guidance for Industry on Extended Release Oral Dosage Forms.Development, Evaluation and Application of In Vitro/In Vivo Correlations. Rockville, MD: FDA, Center for Drug Evaluation and Research; 1997.

    Google Scholar 

  31. Ishii K, Saitou Y, Yamada R, Itai S, Nemoto M. Novel approach for determination of correlation between in vivo and in vitro dissolution using the optimization technique.Chem Pharm Bull (Tokyo). 1996; 44:1550–1555.

    Article  CAS  Google Scholar 

  32. Lin SY, Yang JC. Moment analysis for the evaluation of in vitro drug release and in vivo bioavailability of theophylline microcapsules.Drug Dev Ind Pharm. 1998;14:805–817.

    Article  Google Scholar 

  33. Liu FY, Sambol NC, Giannini RP, Liu CY. In vitro-in vivo relationship of oral extended-release dosage forms.Pharm Res. 1996;13:1501–1506.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Technology, Jadavpur University, 700 032, Kolkata, India

    Shunmugaperumal Tamilvanan & Biswanath Sa

  2. Department of Pharmaceutical Sciences, University of Antwerp, 2610 Wilrijk, Antwerp, Belgium

    Shunmugaperumal Tamilvanan

Authors
  1. Shunmugaperumal Tamilvanan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Biswanath Sa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shunmugaperumal Tamilvanan.

Additional information

Published: September 1, 2006

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tamilvanan, S., Sa, B. In vitro and in vivo evaluation of single-unit commercial conventional tablet and sustained-release capsules compared with multiple-unit polystyrene microparticle dosage forms of ibuprofen. AAPS PharmSciTech 7, 72 (2006). https://doi.org/10.1208/pt070372

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1208/pt070372

Keywords

Search

Navigation